BridgeMD
New treatment option for Respiratory Tract Infections
Official title PREDICATE Trial For Respiratory Tract Infections
ClinicalTrials.gov ID: NCT06472219
What this study is testing
What is Prednisolone 30 mg?
Prednisolone 30 mg is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for respiratory tract infections.
Also referred to as Prednisolone.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Background The goal of this clinical trial is to learn if prednisolone works to treat moderate to severe respiratory tract infections in adults admitted to hospital. It will also learn about the safety of prednisolone in this context.
- Phase 3: a large, late-stage study
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients will be eligible for the study if ALL the following are present:
- Adults ≥18 years of age; AND
- scARI; AND
- Intended hospitalisation; AND
- No medical history that might, in the opinion of the attending clinician, put the patient at significant risk if he/she were to participate in the...
You likely can't join if
- Patients will be excluded if the treating clinician considers that the patient is not suitable for the trial. Patients may be excluded if any ONE of...
- Vulnerable people (pregnancy; cognitively impaired; prisoners; students; umemployee; minorities);
- Cardiac arrest or post-cardiac arrest ROSC;
- Not expected to survive 3 days due to pre-existing chronic disease;
- Palliative (comfort) care
- Undergoing active cancer therapy;
See the full eligibility criteria
- Patients will be eligible for the study if ALL the following are present:
- Adults ≥18 years of age; AND
- scARI; AND
- Intended hospitalisation; AND
- No medical history that might, in the opinion of the attending clinician, put the patient at significant risk if he/she were to participate in the trial
- Patients will be excluded if the treating clinician considers that the patient is not suitable for the trial. Patients may be excluded if any ONE of the following are present:
- Vulnerable people (pregnancy; cognitively impaired; prisoners; students; umemployee; minorities);
- Cardiac arrest or post-cardiac arrest ROSC;
- Not expected to survive 3 days due to pre-existing chronic disease;
- Palliative (comfort) care
- Undergoing active cancer therapy;
- Neutropenia due to chemotherapy/malignancy (but not due to sepsis)
- Immunocompromised or being treated with immunotherapy
- Organ transplantation
- HIV and on HIV drugs (indinavir, atazanavir, nelfinavir, saquinavir, ritonavir)
- Recent Surgery (within one month)
- Dialysis (including CAPD)
- Diabetic ketoacidosis
- Acute asthma
- Recurrent chest infection,
- Cushing's or Addisonian's disease,
- Long term systemic steroid
- Long-term antibiotics
The study team makes the final eligibility decision.
Where it's taking place
- Hong Kong, Hong Kong
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hong Kong, Hong Kong. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.